Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
52,406,487
-
Number of holders
-
113
-
Total 13F shares, excl. options
-
33,935,762
-
Shares change
-
-842,434
-
Total reported value, excl. options
-
$493,769,986
-
Value change
-
-$11,534,913
-
Put/Call ratio
-
45%
-
Number of buys
-
50
-
Number of sells
-
-50
-
Price
-
$14.55
Significant Holders of 2seventy bio, Inc. - Common Stock, par value $0.0001 per share (TSVT) as of Q3 2022
133 filings reported holding TSVT - 2seventy bio, Inc. - Common Stock, par value $0.0001 per share as of Q3 2022.
2seventy bio, Inc. - Common Stock, par value $0.0001 per share (TSVT) has 113 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33,935,762 shares
of 52,406,487 outstanding shares and own 65% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (3,212,011 shares), BlackRock Inc. (2,582,041 shares), VANGUARD GROUP INC (2,355,933 shares), EcoR1 Capital, LLC (2,341,313 shares), STATE STREET CORP (2,300,501 shares), BAKER BROS. ADVISORS LP (2,062,744 shares), Bain Capital Life Sciences Investors, LLC (1,408,901 shares), ARMISTICE CAPITAL, LLC (1,264,000 shares), RTW INVESTMENTS, LP (1,229,508 shares), and Madison Avenue Partners, LP (1,199,832 shares).
This table shows the top 113 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.